Abstract
Purpose
This review investigated survival and alcoholic relapse following liver transplantation (LT) in patients with severe acute alcoholic hepatitis (AH) without 6 months of alcohol abstinence.
Methods
All studies comparing acute AH patients undergoing LT with a control group were included. CENTRAL, MEDLINE, and Web of Science databases were searched. Survival benefits or odds ratios (OR) and 95% confidence intervals (CI) were assessed by meta-analyses using a random effects model. The study was registered in PROSPERO (CRD42017057971). According to the search results, two separate meta-analyses were performed: meta-analysis A compared early LT with medical therapy alone in patients with severe AH that were not responding to medical therapy and meta-analysis B compared LT outcome in patients with AH and chronic alcoholic cirrhosis (AC).
Results
The search yielded 2232 articles. Eight studies were included in the two meta-analyses—two studies in meta-analysis A and six studies in meta-analysis B. The two studies (n = 70) included in meta-analysis A revealed that 1-year patient survival was significantly higher in the LT group compared with the medical therapy–alone group (survival benefit, 15.88; 95% CI, 3.98–63.35; p < 0.0001). The six studies in meta-analysis B (including 1091 patients) showed that 1-year (survival benefit, 1.65; 95% CI, 0.95–2.89; p = 0.08), 3-year (survival benefit, 1.31; 95% CI, 0.79–2.18; p = 0.30), and 5-year survival (survival benefit, 1.54; 95% CI, 0.92–2.56; p = 0.10) were not significantly different between AH and AC groups. There was no significant difference in the rate of alcohol relapse between the groups (OR, 1.26; 95% CI, 0.53–2.96; p = 0.60).
Conclusions
Early LT is a life-saving treatment for AH patients that do not respond to medical therapy. The chance of alcohol relapse after LT is not increased in selected patients.
Similar content being viewed by others
References
Mandrekar P, Bataller R, Tsukamoto H, Gao B (2016) Alcoholic hepatitis: translational approaches to develop targeted therapies. Hepatology 64(4):1343–1355. https://doi.org/10.1002/hep.28530
Fung P, Pyrsopoulos N (2017) Emerging concepts in alcoholic hepatitis. World J Hepatol 9(12):567–585. https://doi.org/10.4254/wjh.v9.i12.567
Singal AK, Kamath PS, Gores GJ, Shah VH (2014) Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol 12(4):555–564; quiz e531–552. https://doi.org/10.1016/j.cgh.2013.06.013
Thursz M, Morgan TR (2016) Treatment of severe alcoholic hepatitis. Gastroenterology 150(8):1823–1834. https://doi.org/10.1053/j.gastro.2016.02.074
Aday AW, Mitchell MC, Casey LC (2017) Alcoholic hepatitis: current trends in management. Curr Opin Gastroenterol 33(3):142–148. https://doi.org/10.1097/mog.0000000000000359
Lanthier N, Starkel P (2017) Treatment of severe alcoholic hepatitis: past, present and future. Eur J Clin Investig 47(7):531–539. https://doi.org/10.1111/eci.12767
European Association for the Study of Liver (2012) EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 57(2):399–420. https://doi.org/10.1016/j.jhep.2012.04.004
Im GY, Kim-Schluger L, Shenoy A, Schubert E, Goel A, Friedman SL, Florman S, Schiano TD (2016) Early liver transplantation for severe alcoholic hepatitis in the United States--a single-center experience. Am J Transplant 16(3):841–849. https://doi.org/10.1111/ajt.13586
Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, Castel H, Duhamel A, Pageaux GP, Leroy V, Dharancy S, Louvet A, Boleslawski E, Lucidi V, Gustot T, Francoz C, Letoublon C, Castaing D, Belghiti J, Donckier V, Pruvot FR, Duclos-Vallee JC (2011) Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 365(19):1790–1800. https://doi.org/10.1056/NEJMoa1105703
Schneekloth TD, Niazi SK, Simonetto DA (2017) Alcoholic hepatitis: appropriate indication for liver transplantation? Curr Opin Organ Transplant 22(6):578–583. https://doi.org/10.1097/mot.0000000000000468
Jesudian AB, Brown RS Jr (2016) Acute alcoholic hepatitis as indication for liver transplantation. Curr Opin Organ Transplant 21(2):107–110. https://doi.org/10.1097/mot.0000000000000285
Hwang S, Lee SG, Kim KK, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW (2006) Efficacy of 6-month pretransplant abstinence for patients with alcoholic liver disease undergoing living donor liver transplantation. Transplant Proc 38(9):2937–2940. https://doi.org/10.1016/j.transproceed.2006.08.139
Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P (2007) The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 45(6):1348–1354. https://doi.org/10.1002/hep.21607
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1. https://doi.org/10.1186/2046-4053-4-1
Goossen K, Tenckhoff S, Probst P, Grummich K, Mihaljevic AL, Buchler MW, Diener MK (2018) Optimal literature search for systematic reviews in surgery. Langenbeck’s Arch Surg 403(1):119–129. https://doi.org/10.1007/s00423-017-1646-x
Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical Research Ed) 355:i4919. https://doi.org/10.1136/bmj.i4919
Weeks SR, Sun Z, McCaul ME, Zhu H, Anders RA, Philosophe B, Ottmann SE, Garonzik Wang JM, Gurakar AO, Cameron AM (2018) Liver transplantation for severe alcoholic hepatitis, updated lessons from the world’s largest series. J Am Coll Surg 226(4):549–557. https://doi.org/10.1016/j.jamcollsurg.2017.12.044
Wells JT, Said A, Agni R, Tome S, Hughes S, Dureja P, Lucey MR (2007) The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation. Liver Transpl 13(12):1728–1735. https://doi.org/10.1002/lt.21298
Bonet H, Manez R, Kramer D, Wright HI, Gavaler JS, Baddour N, Van Thiel DH (1993) Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. Transplant Proc 25(1 Pt 2):1126–1127
Tome S, Martinez-Rey C, Gonzalez-Quintela A, Gude F, Brage A, Otero E, Abdulkader I, Forteza J, Bustamante M, Varo E (2002) Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol 36(6):793–798
Shakil AO, Pinna A, Demetris J, Lee RG, Fung JJ, Rakela J (1997) Survival and quality of life after liver transplantation for acute alcoholic hepatitis. Liver Transpl 3(3):240–244
Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF (2012) Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology 55(5):1398–1405. https://doi.org/10.1002/hep.25544
Lieber SR, Rice JP, Lucey MR, Bataller R (2017) Controversies in clinical trials for alcoholic hepatitis. J Hepatol 68:586–592. https://doi.org/10.1016/j.jhep.2017.09.013
Mathurin P, Bataller R (2015) Trends in the management and burden of alcoholic liver disease. J Hepatol 62(1 Suppl):S38–S46. https://doi.org/10.1016/j.jhep.2015.03.006
Arsene D, Farooq O, Bataller R (2016) New therapeutic targets in alcoholic hepatitis. Hepatol Int 10(4):538–552. https://doi.org/10.1007/s12072-015-9701-6
Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, Downs N, Gleeson D, MacGilchrist A, Grant A, Hood S, Masson S, McCune A, Mellor J, O’Grady J, Patch D, Ratcliffe I, Roderick P, Stanton L, Vergis N, Wright M, Ryder S, Forrest EH (2015) Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 372(17):1619–1628. https://doi.org/10.1056/NEJMoa1412278
Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, Ghobrial RM, Dodge JL, Li Z, Terrault NA (2018) Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology 155:422–430.e1. https://doi.org/10.1053/j.gastro.2018.04.009
Cholankeril G, Perumpail RB, Hu M, Yoo ER, Liu A, Chalasani NP, Ahmed A (2016) Acute Alcoholic Hepatitis has comparable survival following liver transplantation to other causes of acute liver failure. In: Hepatology. vol 1 SUPP. WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030–5774, NJ USA, pp 617A–617A
Van Thiel DH, Bonet H, Gavaler J, Wright HI (1995) Effect of alcohol use on allograft rejection rates after liver transplantation for alcoholic liver disease. Alcohol Clin Exp Res 19(5):1151–1155
Immordino G, Gelli M, Ferrante R, Ferrari C, Piaggio F, Ghinolfi D, Sturdevant M, Andorno E, Morelli N, Bottino G, Casaccia M, Valente U (2009) Alcohol abstinence and orthotopic liver transplantation in alcoholic liver cirrhosis. Transplant Proc 41(4):1253–1255. https://doi.org/10.1016/j.transproceed.2009.03.092
Bundesärztekammer B (2011) Richtlinien für die Wartelistenführung und die Organvermittlung gem. § 16 Abs. 1 S. 1 Nrn. 2 u. 5 TPG
Dureja P, Lucey MR (2010) The place of liver transplantation in the treatment of severe alcoholic hepatitis. J Hepatol 52(5):759–764. https://doi.org/10.1016/j.jhep.2009.12.021
Obed A, Stern S, Jarrad A, Lorf T (2015) Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients. World J Gastroenterol 21(14):4423–4426. https://doi.org/10.3748/wjg.v21.i14.4423
BGH 5 StR 20/16 - Urteil vom 28. Juni 2017 (LG Göttingen). https://www.hrr-strafrecht.de/hrr/5/16/5-20-16.php
DiMartini A, Day N, Dew MA, Javed L, Fitzgerald MG, Jain A, Fung JJ, Fontes P (2006) Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 12(5):813–820. https://doi.org/10.1002/lt.20688
Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nussler NC (2007) Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 13(2):197–205. https://doi.org/10.1002/lt.20934
Hajifathalian K, Humberson A, Hanouneh MA, Barnes DS, Arora Z, Zein NN, Eghtesad B, Kelly D, Hanouneh IA (2016) Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease. World J Hepatol 8(27):1149–1154. https://doi.org/10.4254/wjh.v8.i27.1149
Weinrieb RM, Van Horn DH, McLellan AT, Lucey MR (2000) Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery. Liver Transpl 6(6):769–776. https://doi.org/10.1053/jlts.2000.18497
Starzl TE, Van Thiel D, Tzakis AG, Iwatsuki S, Todo S, Marsh JW, Koneru B, Staschak S, Stieber A, Gordon RD (1988) Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 260(17):2542–2544
Donckier V, Lucidi V, Gustot T, Moreno C (2014) Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy. J Hepatol 60(4):866–871. https://doi.org/10.1016/j.jhep.2013.11.015
Lee BP, Chen PH, Haugen C, Hernaez R, Gurakar A, Philosophe B, Dagher N, Moore SA, Li Z, Cameron AM (2017) Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis. Ann Surg 265(1):20–29. https://doi.org/10.1097/SLA.0000000000001831
Hasanin M, Dubay DA, McGuire BM, Schiano T, Singal AK (2015) Liver transplantation for alcoholic hepatitis: a survey of liver transplant centers. Liver Transpl 21(11):1449–1452. https://doi.org/10.1002/lt.24208
Stroh G, Rosell T, Dong F, Forster J (2015) Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation. Am J Transplant 15(6):1598–1604. https://doi.org/10.1111/ajt.13176
Acknowledgements
The protocol of this study was registered prior to conducting the research in the international prospective register of systematic reviews (PROSPERO: CRD42017057971) on 23 February 2017.
Funding
This systematic review and meta-analysis was funded by a grant from the Heidelberg Stiftung Chirurgie (Heidelberg Foundation for Surgery).
Author information
Authors and Affiliations
Contributions
AM and MKD designed the study. MAS, MHB, PP, and EK performed the database search and acquired the data. MAS, MHB, and EK performed the statistical analysis and interpretation of the data and drafted the manuscript. KHW, MKD, and AM revised the manuscript critically for important intellectual content. All authors read and approved the final version of the manuscript to be published.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
This manuscript is a meta-analysis; it does not contain any procedures involving human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from all participants involved in this study.
Rights and permissions
About this article
Cite this article
Al-Saeedi, M., Barout, M.H., Probst, P. et al. Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis. Langenbecks Arch Surg 403, 825–836 (2018). https://doi.org/10.1007/s00423-018-1720-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-018-1720-z